These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial. Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174 [TBL] [Abstract][Full Text] [Related]
4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related]
5. Interactions between malaria and human immunodeficiency virus anno 2014. Van Geertruyden JP Clin Microbiol Infect; 2014 Apr; 20(4):278-85. PubMed ID: 24528518 [TBL] [Abstract][Full Text] [Related]
6. The Treatment of Plasmodium knowlesi Malaria. Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609 [TBL] [Abstract][Full Text] [Related]
7. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread. Woodrow CJ; White NJ FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271 [TBL] [Abstract][Full Text] [Related]
9. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of artemisinin-based combination therapies. German PI; Aweeka FT Clin Pharmacokinet; 2008; 47(2):91-102. PubMed ID: 18193915 [TBL] [Abstract][Full Text] [Related]
11. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813 [TBL] [Abstract][Full Text] [Related]
12. Malaria: an update for physicians. Nadjm B; Behrens RH Infect Dis Clin North Am; 2012 Jun; 26(2):243-59. PubMed ID: 22632637 [TBL] [Abstract][Full Text] [Related]
13. Malaria. Fletcher TE; Beeching NJ J R Army Med Corps; 2013 Sep; 159(3):158-66. PubMed ID: 24109136 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children. Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666 [TBL] [Abstract][Full Text] [Related]
16. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Barradell LB; Fitton A Drugs; 1995 Oct; 50(4):714-41. PubMed ID: 8536555 [TBL] [Abstract][Full Text] [Related]